Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Amphastar Pharma (AMPH)
Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amphastar Pharma 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 USA

www.amphastar.com P: 909-980-9484

Description:

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Key Statistics

Overview:

Market Capitalization, $K 2,606,620
Enterprise Value, $K 2,526,180
Shares Outstanding, K 47,907
Annual Sales, $ 498,990 K
Annual Net Income, $ 91,390 K
Last Quarter Sales, $ 180,560 K
Last Quarter Net Income, $ 49,220 K
EBIT, $ 180,840 K
EBITDA, $ 206,080 K
60-Month Beta 0.87
% of Insider Shareholders 28.40%
% of Institutional Shareholders 65.09%
Float, K 34,301
% Float 71.60%
Short Volume Ratio 0.68

Growth:

1-Year Return 90.56%
3-Year Return 194.14%
5-Year Return 153.48%
5-Year Revenue Growth 107.76%
5-Year Earnings Growth 347.37%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.15 on 11/08/23
Next Earnings Date N/A
Earnings Per Share ttm 2.85
EPS Growth vs. Prev Qtr 86.21%
EPS Growth vs. Prev Year 237.50%
Annual Dividend Yield 0.00%
Dividend Payable Date 06/11/10
Dividend Payout Ratio 0.00%

AMPH Ratios

Ratio
Price/Earnings ttm 19.86
Price/Earnings forward 19.57
Price/Earnings to Growth 0.86
Return-on-Equity % 26.68%
Return-on-Assets % 13.60%
Profit Margin % 18.32%
Net Margin % N/A
Debt/Equity 0.83
Price/Sales 5.43
Price/Cash Flow 24.05
Price/Book 4.61
Book Value/Share 12.33
Interest Coverage 63.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar